SLC16A3 and diffuse large B-cell lymphoma: NUDHL1 and OCILY-19 DLBCL cells were also included as they express comparatively high levels of SLC16A3 (MCT4 gene) mRNA (Supplementary Fig. S1a), and were therefore considered likely to demonstrate resistance to MCT1 inhibition.